FDA Clears Roche Point-of-Care STI Tests
The FDA granted 510(k) clearance for Roche STI multiplex panels, enabling rapid diagnosis of chlamydia, gonorrhea, and Mycoplasma genitalium.
Read MorePosted by Andy Lundin | Jan 22, 2025 | Point-of-Care, Sexually Transmitted Diseases |
The FDA granted 510(k) clearance for Roche STI multiplex panels, enabling rapid diagnosis of chlamydia, gonorrhea, and Mycoplasma genitalium.
Read MorePosted by Andy Lundin | Sep 18, 2024 | Podcasts, Point-of-Care |
In this episode of Clinical Lab Chat, Seth Egan of Co-Diagnostics discusses how POC testing improves both diagnostic and treatment access.
Read MorePosted by Chris Wolski | Jun 28, 2024 | POC Reagents & Test Kits |
The FDA has authorized Cepheid’s Xpert HCV test and GeneXpert Xpress System, the first point-of-care HCV test for certified settings.
Read MorePosted by Andy Lundin | Mar 1, 2024 | Emerging & Zoonotic Diseases |
Researchers developed a rapid, accurate test for diagnosing malaria that is significantly faster and easier to use than traditional tests.
Read MorePosted by Chris Wolski | Sep 26, 2023 | Sepsis |
Steripath delivers critical time savings for sepsis diagnosis, improving patient outcomes and providing cost efficiencies.
Read More